Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

FDA on breakthrough therapy requests by status 2018

Distribution of FDA breakthrough therapy request statuses in 2018

by Matej Mikulic, last edited Jan 3, 2019
FDA on breakthrough therapy requests by status 2018 This statistic displays the share of FDA statuses of breakthrough therapy requests in the United States in 2018. As of end-November of that year, 46 percent of requests had been denied. The FDA recommends that submissions for breakthrough therapy designations should be made prior to phase III.
Show more

Distribution of FDA breakthrough therapy request statuses in 2018

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Oncology"
  • Cancer facts
The most important statistics
  • Oncology market
  • Companies
  • Cancer drugs
  • Research and development
  • Immuno-oncology
  • Treatment types
  • Physicians and patients
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.